摘要
背景:最近涉及纳米技术和基因治疗的综合方法加快了向中枢神经系统(CNS)高效药物输送的发展。神经退行性疾病与遗传遗传和突变密切相关。 材料:纳米技术已经允许对各种聚合物结构进行有效的工程。此外,广泛的聚合物材料的可用性使生物相容性和生物可降解运载工具的制造成为可能。我们的手稿集中在理想的特性和性能的聚合物纳米粒子,使成功的基因治疗神经退行性疾病,以及挑战,提出了实际应用中的困难。我们通过聚合物纳米颗粒的例子强调了这些方面,在治疗神经紊乱和突变方面已经显示出治疗前景。 方法:彻底治愈这些疾病是一项具有挑战性的任务,基因治疗似乎是一种现实的治疗方法。基因疗法可以有效地替换或抑制有缺陷的基因,从而增加神经元存活和修复的机会。然而,成功地将裸遗传物质运送到中枢神经系统面临着严重的障碍,可能是由于这些生物实体在血脑屏障(BBB)上的降解和限制运输。在结构上,血脑屏障由几个紧密连接组成,使膜对分子的进入具有高度选择性。 结论:靶向血脑屏障治疗神经退行性疾病的关键在于研制一种既能跨越这一屏障又能有效调控致病基因表达的特制系统。使用纳米颗粒作为载体,可能有助于稳定治疗基因及其有效靶向递送。
关键词: 基因治疗,阿尔茨海默病,帕金森病,亨廷顿氏病,肌萎缩侧索硬化,血脑屏障,高分子纳米粒
Current Gene Therapy
Title:Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems
Volume: 17 Issue: 2
关键词: 基因治疗,阿尔茨海默病,帕金森病,亨廷顿氏病,肌萎缩侧索硬化,血脑屏障,高分子纳米粒
摘要: Background: Recent integrated approaches involving nanotechnology and gene therapy have accelerated development of efficient drug delivery to the central nervous system (CNS). Neurodegenerative disorders are closely associated with genetic inheritance and mutation.
Materials: Nanotechnology has allowed effective engineering of various such polymeric structures. Moreover, availability of a wide array of polymeric materials has enabled fabrication of biocompatible and biodegradable delivery vehicles. Our manuscript focuses on the ideal features and properties of polymeric nanoparticles that have enabled successful gene therapy for neurodegenerative disorders, as well as the challenges that are posing difficulties in their practical application. We have highlighted these aspects through examples of polymeric nanoparticles that have exhibited therapeutic promise in the treatment of neurological disorders and mutations. Methods: Complete cure of these diseases is a challenging task and gene therapy appears as a realistic approach for their treatment. Gene therapy allows effective replacement or suppression of faulty genes, thereby increasing chances for neuron survival and repair. However, successful delivery of naked genetic material to CNS faces severe obstacles due to possible degradation and restricted transportation of these biological entities across the blood brain barrier (BBB). Structurally, the BBB is composed of several tight junctions, making the membrane highly selective towards the entry of molecules. Conclusion: In order to target BBB for treating neurodegenerative diseases, it is essential to develop a tailor-made system that may not only cross this barrier, but also effectively modulate the expression of disease-causing genes. Stabilization of therapeutic genes and their effective, targeted delivery may be possible using polymeric nanoparticles as carriers.Export Options
About this article
Cite this article as:
Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems, Current Gene Therapy 2017; 17 (2) . https://dx.doi.org/10.2174/1566523217666170510153845
DOI https://dx.doi.org/10.2174/1566523217666170510153845 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progranulin Regulates Inflammation and Tumor
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Are the Extracelluar Pathways a Conduit for the Delivery of Therapeutics to the Brain?
Current Pharmaceutical Design Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design DNA Secondary Structure at Chromosomal Fragile Sites in Human Disease
Current Genomics Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
Current Molecular Medicine Past, Present and Future of Nutrigenomics and its Influence on Drug Development
Current Drug Discovery Technologies Molecular Mechanisms Determining Opposed Functional States of Microglia
Current Neuropharmacology The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders I: Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Metabolic Aspects of Prion Diseases: An Overview
Current Drug Targets Antioxidants in Treating Pathologies Involving Oxidative Damage: An Update on Medicinal Chemistry and Biological Activity of Stobadine and Related Pyridoindoles
Current Medicinal Chemistry Oxidative Stress in Schizophrenia
Current Neuropharmacology Antioxidants Suppress Th1-Type Immune Response In Vitro
Drug Metabolism Letters Effects of Transition Metals in the Conversion Mechanism of Prion Protein and in the Pathogenesis of Prion Diseases
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Determination of Spatial and Temporal Distribution of Microglia by 230nm-High-Resolution, High-Throughput Automated Analysis Reveals Different Amyloid Plaque Populations in an APP/PS1 Mouse Model of Alzheimers Disease
Current Alzheimer Research Editorial [Hot topic: Inhibition and Function of Heat Shock Proteins 70 and 90 (Guest Editor: Brian S. J. Blagg)]
Current Topics in Medicinal Chemistry Neurogenesis and Stroke
CNS & Neurological Disorders - Drug Targets Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntingtons Disease Phenotype
CNS & Neurological Disorders - Drug Targets